Yiwei Chu

10.5k citations

183 papers · 7.9k · 2 hit papers · h-index 51

Impact in

Immunology top 0.5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
- T-cell and B-cell Immunology
- Immune Response and Inflammation
Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in

Immunology 113
- Immune Cell Function and Interaction 50
- Immunotherapy and Immune Responses 43
- T-cell and B-cell Immunology 32
- Immune Response and Inflammation 24
- Immune cells in cancer 22
Molecular Biology 53

Co-authors: Feifei Luo (26 shared papers)Sidong Xiong (29 shared papers)Luman Wang (31 shared papers)Ronghua Liu (17 shared papers)Shudao Xiong (10 shared papers)Xue Yang (5 shared papers)Yijie Zheng (9 shared papers)Ronghua Liu (16 shared papers)
Journals: Frontiers in Immunology (7 papers)PLoS ONE (6 papers)Oncotarget (6 papers)Cancer Research (6 papers)Immunology (6 papers)
Partner nations: China United States South Korea

In The Last Decade

Yiwei Chu

180 papers receiving 7.8k citations

Yiwei Chu's Hit Papers

align trajectories log scale

FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling 2016 · 581 citations

Peers

Countries citing papers authored by Yiwei Chu

Since Specialization

Citations

This map shows the geographic impact of Yiwei Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiwei Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiwei Chu more than expected).

Fields of papers citing papers by Yiwei Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiwei Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiwei Chu. The network helps show where Yiwei Chu may publish in the future.

Co-authors

The 25 scholars most cited alongside Yiwei Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yiwei Chu Line = papers co-authored together Yiwei Chu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 183 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling Cancer Research ·Xuguang Yang, Yuli Lin, (unknown), Bingji Li, Weiren Liu, Wei Yin, Yongjun Dang, Yiwei Chu, Jia Fan, Rui He Hit paper breakdown →	2016	581
2	Th17 and natural Treg cell population dynamics in systemic lupus erythematosus Arthritis & Rheumatism ·Ji Yang, Yiwei Chu, Xue Yang, Di Gao, Lubing Zhu, Xin‐Rong Yang, Linlin Wan, Ming Li Hit paper breakdown →	2009	380
3	SIRT5 Desuccinylates and Activates Pyruvate Kinase M2 to Block Macrophage IL-1β Production and to Prevent DSS-Induced Colitis in Mice Cell Reports ·Fang Wang, Ke Wang, Wei Xu, Shimin Zhao, Dan Ye, Yi Wang, Ying Xu, Lisha Zhou, Yiwei Chu, Cuiping Zhang, Xue Qin, Pengyuan Yang, Hongxiu Yu	2017	272
4	The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy Journal of Neuroinflammation ·Jiawen Qian, Chen Wang, Bo Wang, Jiao Yang, Yuedi Wang, Feifei Luo, Junying Xu, Chujun Zhao, Ronghua Liu, Yiwei Chu	2018	209
5	The Nedd8-Activating Enzyme Inhibitor MLN4924 Induces Autophagy and Apoptosis to Suppress Liver Cancer Cell Growth Cancer Research ·Zhongguang Luo, Guangyang Yu, Hyuk Woo Lee, Lihui Li, Lingyan Wang, Dongqin Yang, Yongfu Pan, Chan Ding, Jing Qian, Lijun Wu, Yiwei Chu, Jing Yi, Xiangdong Wang, Yi Sun, Lak Shin Jeong, Jie Liu, Lijun Jia	2012	202
6	Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy Clinical Immunology ·Lei Zhang, Kam-tai Dermawan, Meilin Jin, Rongjun Liu, Huiru Zheng, Lin Xu, Yi Zhang, Yuchan Cai, Yiwei Chu, Sidong Xiong	2008	174
7	SIRT1 Limits the Function and Fate of Myeloid-Derived Suppressor Cells in Tumors by Orchestrating HIF-1 α –Dependent Glycolysis Cancer Research ·Guangwei Liu, Yujing Bi, Bo Shen, Hui Yang, Yan Zhang, Xiao Wang, Huanrong Liu, Yun Lu, Jiongbo Liao, Xi Chen, Yiwei Chu	2013	171
8	MicroRNA-7 Inhibits the Growth of Human Non-Small Cell Lung Cancer A549 Cells through Targeting BCL-2 International Journal of Biological Sciences ·Shudao Xiong, Yijie Zheng, Pei Jiang, Ronghua Liu, Xiaoming Liu, Yiwei Chu	2011	168
9	Lipid metabolism in inflammation-related diseases The Analyst ·Cuiping Zhang, Ke Wang, Lujie Yang, Ronghua Liu, Yiwei Chu, Xue Qin, Pengyuan Yang, Hongxiu Yu	2018	143
10	Differential Expression of CXCR4 Is Associated with the Metastatic Potential of Human Non–Small Cell Lung Cancer Cells Clinical Cancer Research ·Liping Su, Jinping Zhang, Huanbin Xu, Ying Wang, Yiwei Chu, Rui-Zi Liu, Sidong Xiong	2005	133
11	Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma Journal of Hematology & Oncology ·Gils Roex, Marijke Timmers, Kristien Wouters, Diana Campillo-Davó, Donovan Flumens, Wilfried Schroyens, Yiwei Chu, Zwi Berneman, Eva Lion, Feifei Luo, Sébastien Anguille	2020	126
12	Involvement of cellular death in TRAIL/DR5-dependent suppression induced by CD4+CD25+ regulatory T cells Cell Death and Differentiation ·X. Ren, F Ye, Zhenggang Jiang, Yiwei Chu, Sidong Xiong, Y Wang	2007	112
13	TLR1/TLR2 Agonist Induces Tumor Regression by Reciprocal Modulation of Effector and Regulatory T Cells The Journal of Immunology ·Yi Zhang, Feifei Luo, Yuchan Cai, Nan Liu, Luman Wang, Damo Xu, Yiwei Chu	2011	102
14	DNMT1–MicroRNA126 Epigenetic Circuit Contributes to Esophageal Squamous Cell Carcinoma Growth via ADAM9–EGFR–AKT Signaling Clinical Cancer Research ·Ronghua Liu, Jie Gu, Pei Jiang, Yijie Zheng, Xiaoming Liu, Xuechao Jiang, Enyu Huang, Shudao Xiong, Fengkai Xu, Guangwei Liu, Di Ge, Yiwei Chu	2014	97
15	Prognostic significance of the IASLC/ATS/ERS classification in Chinese patients—A single institution retrospective study of 292 lung adenocarcinoma Journal of Surgical Oncology ·Jie Gu, Chunlai Lu, Jing Guo, Lingli Chen, Yiwei Chu, Yuan Ji, Di Ge	2012	96
16	Multifaceted Modulation of SIRT1 in Cancer and Inflammation Critical Reviews™ in Oncogenesis ·Hui Yang, Yujing Bi, Lixiang Xue, Jian Wang, Yun Lu, Zhengguo Zhang, Xi Chen, Yiwei Chu, Ruifu Yang, Ruoning Wang, Guangwei Liu	2014	96
17	Dendritic cell SIRT1–HIF1α axis programs the differentiation of CD4 ⁺ T cells through IL-12 and TGF-β1 Proceedings of the National Academy of Sciences ·Guangwei Liu, Yujing Bi, Lixiang Xue, Yan Zhang, Hui Yang, Xi Chen, Yun Lu, Zhengguo Zhang, Huanrong Liu, Xiao Wang, Ruoning Wang, Yiwei Chu, Ruifu Yang	2015	95
18	MiR-34a inhibits lipopolysaccharide-induced inflammatory response through targeting Notch1 in murine macrophages Experimental Cell Research ·Pei Jiang, Ronghua Liu, Yijie Zheng, Xiaoming Liu, Lijun Chang, Shudao Xiong, Yiwei Chu	2012	94
19	T Follicular Helper Cells and Regulatory B Cells Dynamics in Systemic Lupus Erythematosus PLoS ONE ·Xue Yang, Ji Yang, Yiwei Chu, Yu Xue, Dandan Xuan, Shucong Zheng, Hejian Zou	2014	92
20	Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial Cancer Immunology Immunotherapy ·Yu Yao, Feifei Luo, Chao Tang, Dikang Chen, Zhiyong Qin, Wei Hua, Ming Xu, Ping Zhong, Shuangquan Yu, Di Chen, Xiaojie Ding, Yi Zhang, Xiujuan Zheng, Jiao Yang, Jiawen Qian, Yuting Deng, Dave S.�B. Hoon, Jian Hu, Yiwei Chu, Liangfu Zhou	2018	91

About Yiwei Chu

Yiwei Chu is a scholar working on Immunology, Molecular Biology, Oncology, Epidemiology and Cancer Research, having authored 183 papers that have together received 7.9k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (50 papers), Immunotherapy and Immune Responses (43 papers), T-cell and B-cell Immunology (32 papers), Immune Response and Inflammation (24 papers), Immune cells in cancer (22 papers), CAR-T cell therapy research (16 papers), Cancer Immunotherapy and Biomarkers (14 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). The work is most often cited by research in Immunology (3.3k citations), Oncology (2.2k citations), Cancer Research (1.1k citations), Geriatrics and Gerontology (197 citations) and Molecular Biology (2.6k citations). Yiwei Chu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Feifei Luo, Sidong Xiong, Luman Wang, Ronghua Liu, Shudao Xiong, Xue Yang, Yijie Zheng, Ronghua Liu, Rui He and Ji Yang. Their work appears in journals such as Frontiers in Immunology, PLoS ONE, Oncotarget, Cancer Research and Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Yiwei Chu

Impact in

Papers in i

In The Last Decade

Yiwei Chu

Yiwei Chu's Hit Papers

Peers

Countries citing papers authored by Yiwei Chu

Fields of papers citing papers by Yiwei Chu

All Works

About Yiwei Chu

Explore authors with similar magnitude of impact

Papers in